Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
All BPC-157 peptides dispensed by our clinic are produced in FDA-monitored facilities and intended for physician-supervised research and therapeutic use only not for purchase from online research sources, which often contain impure or mislabeled products
A vial labeled for research use is not the same as a patient-specific prescription
Two collagen types dominate: Type I collagen (mature tendon structure) Type III collagen (early repair phase) In rodent studies, BPC-157-treated tendons showed: Increased type I collagen deposition Improved fiber parallel alignment Better biomechanical strength This suggests influence over: TGF- signalling Matrix metalloproteinases (MMPs) Extracellular matrix remodelling enzymes Balanced ECM remodelling prevents disorganized scar tissue
It's about restoring or amplifying what should already be happening which is why the side effect profiles of most therapeutic peptides are generally favorable, and why this category of treatment has attracted significant clinical research interest over the past decade
For histological examination, H&E staining was carried out
